# A Study to Evaluate the Effect of Formulation and Food on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-011)

> **NCT06942741** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 52 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Calderasib OCT
- **DRUG:** Calderasib FCT

## Key facts

- **NCT ID:** NCT06942741
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-05-13
- **Primary completion:** 2025-06-22
- **Final completion:** 2025-08-04
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2026-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06942741

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06942741, "A Study to Evaluate the Effect of Formulation and Food on Calderasib (MK-1084) in Healthy Adult Participants (MK-1084-011)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06942741. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*